Break the GPO Ceiling: Get the Guide
  • Specialty Infusion Services

Providing infusion-based therapies beyond those specific to cancer

We offer specialty infusion therapies for patients with chronic diseases or conditions to treat anemia, Crohn’s, multiple sclerosis, rheumatoid arthritis and more. Under the supervision of our Board-certified physicians, our dedicated teams of oncology-certified nurses and pharmacy technicians are trained in preparing and managing complex infusions and addressing side effects that may occur.

Expert care delivery

Our pharmacy staff are highly knowledgeable in preparing biologic infusions. Every patient receiving infusion is under the care of a licensed and certified nurse with expertise in administering infusion-based medications and identifying and managing reactions.

Cost-effective option

We provide high quality, infusion therapy at a lower cost to patients and payers. Patients who receive infusion treatment in a hospital outpatient setting often incur higher costs than patients receiving treatment in a community-based practice.

Comfortable and convenient

With care that centers around the patient, our physicians and nurses take the time to get to know each patient – care is personal and delivered safely with compassion and comfort in mind. With offices conveniently located within the community, patients do not have to go far to get the very best in care.

Integrated patient care

We work with the patients’ referring physician to ensure a seamless patient experience. Our process includes collecting records, information and other needs before the patient arrives for treatment, so we are ready to provide care.

Referring Specialties with whom we partner:

  • Rheumatology
  • Allergy and Immunology
  • Dermatology
  • Pulmonology
  • Gastroenterology
  • Neurology
  • Benign Hematology

Medications available for infusion therapy at AON:

  • Actemra (Tocilizumab)
  • Benlysta (Belimumab)
  • Entyvio (Vedolizumab)
  • Iron Products
  • Immunoglobulins (IV and SQ)
  • Ocrevus (Ocrelizumab)

We use cookies and similar technologies to operate our website. We also use cookies to improve your experience, analyze website performance, and provide personalized content, including through our analytics and advertising partners. You can choose which optional cookies to allow by selecting Cookie Preferences. Essential cookies are always enabled because they are necessary for the website to function properly. By selecting Accept All, you consent to our use of optional cookies as described in our Website Privacy & Cookie Notice

We use required cookies to operate the site. With your consent, we use optional cookies and similar technologies for enhanced features, analytics, and advertising.